The director of the Dartmouth Epilepsy Program discussed a few of the notable highlights and themes from the recently completed American Epilepsy Society Annual Meeting.
"There’s a lot of excitement around gene therapy for sure. I also noticed a lot of discussion on neuromodulation therapy and surgical treatments.”
The American Epilepsy Society (AES) recently concluded their annual meeting, held December 4–8, 2020, and featured countless number of abstracts that built on the vastly booming epilepsy research community. This year’s meeting was a bit different than years past, though. Due to the COVID-19 pandemic, the meeting was done virtually, but that did not prohibit the meeting’s events to continue, with all key speakers still taking part.
Barbara Jobst, MD, director of the Dartmouth Epilepsy Program and chairwoman of AES 2020, was thankful that the meeting was able to run smoothly, above everything else. She claims the influx of research and dedication to the space is always encouraging, even if it is restricted to a virtual setting.
In an interview with NeurologyLive, Jobst outlined a few of the more notable topics from this year’s event, with a stress on the creativity and range of types of research presented.